Need professional-grade analysis? Visit stockanalysis.com
$69.89M
N/A
N/A
N/A
MediciNova Inc (MNOV) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $1.41, down 0.70% from the previous close.
Over the past year, MNOV has traded between a low of $1.18 and a high of $1.88. The stock has lost 5.4% over this period. It is currently 25.0% below its 52-week high.
MediciNova Inc has a market capitalization of $69.89M.
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
Side-by-side comparison against top Healthcare peers.